Skip to main content

Primary Research · 2019

Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (VITAL trial)

Manson JE, Cook NR, Lee IM, et al. · New England Journal of Medicine, 2019

Key finding

Large primary-prevention RCT (n=25,871) found n-3 fatty acid supplementation did not reduce major cardiovascular events overall but did reduce myocardial infarction risk, with greatest benefit in low-fish-intake participants.

About the supplement

Omega-3 Fatty Acids

Dose · mechanism · evidence grade · safety →

Read the paper

Open on PubMed

https://pubmed.ncbi.nlm.nih.gov/30415637/

Cited in 1 guide

About this page

Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.

The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →

Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.